Relationships of Work Productivity and Activity Impairment With Patient‐Reported Outcomes in Ankylosing Spondylitis: Results From Two Trials
Arthritis Care & Research · 2024
DOI: 10.1002/acr.25267 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis Care & Research, 2024. Verfasst von Marina Magrey und 6 weiteren Autor:innen. Beteiligte Einrichtung: Case Western Reserve University and Division of Rheumatology, University Hospitals Cleveland Medical Center, Cleveland, Ohio. Hauptthemen laut MEDLINE: Spondylitis, Ankylosing. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Pfizer.
Abstract (Originalsprache)
Objective
We examined the relationships of work productivity and activity impairment with key patient‐reported outcomes (PROs) assessing pain, disease activity, and health‐related quality of life (HRQoL) in patients with ankylosing spondylitis (AS).
Methods
This post hoc analysis pooled available data from baseline to end of the double‐blind phase of phase 2 and 3 placebo‐controlled tofacitinib trials in patients with active AS. A repeated‐measures longitudinal model assessed the relationships (linear or nonlinear) between Work Productivity and Activity Impairment questionnaire in Spondyloarthritis (WPAI:SpA) domains (absenteeism, activity impairment, presenteeism, and productivity loss) as outcomes and key PROs (total back pain, nocturnal spinal pain, Patient Global Assessment of Disease Activity, AS Quality of Life, EuroQol 5‐Dimension 3‐Level [EQ‐5D‐3L], and EQ‐5D Visual Analog Scale [EQ‐5D‐VAS]) as predictors.
Results
Data from 330 to 475 patients were available, depending on the analysis. Relationships between WPAI:SpA domains and PROs were approximately linear. The worst PRO scores were associated with a decline in patients’ work capacity (measured by activity impairment, presenteeism, and productivity loss [>65%]); the best scores were associated with improvements in WPAI:SpA domains (8%–23%). Incremental PRO improvements were associated with improvement of activity impairment, presenteeism, and productivity loss. Relationships between absenteeism and PROs were the weakest, owing to absenteeism being low in the study population.
Conclusion
Evidence of linear relationships between work productivity and activity impairment with patient‐reported pain, disease activity, and HRQoL was observed. Interventions to control pain and disease activity and improve HRQoL are therefore likely to improve work productivity and reduce activity impairment in patients with AS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Case Western Reserve University and Division of Rheumatology, University Hospitals Cleveland Medical Center, Cleveland, Ohio.
- Chung Shan Medical University Hospital and Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.
- Pfizer Inc, Oslo, Norway.
- Pfizer Inc, Groton, Connecticut.
- Pfizer Inc, New York City, New York.
- Oregon Health & Science University, Portland, Oregon.
ORCID-Profile: Marina Magrey, Atul Deodhar
Förderung
- Pfizer
Zitieren
APA
Magrey, M., Wei, J. C., Yndestad, A., Bushmakin, A. G., Cappelleri, J. C., Dina, O., & Deodhar, A. (2024). Relationships of Work Productivity and Activity Impairment With Patient‐Reported Outcomes in Ankylosing Spondylitis: Results From Two Trials. Arthritis Care & Research. https://doi.org/10.1002/acr.25267
Vancouver
Magrey M, Wei JC, Yndestad A, Bushmakin AG, Cappelleri JC, Dina O, et al. Relationships of Work Productivity and Activity Impairment With Patient‐Reported Outcomes in Ankylosing Spondylitis: Results From Two Trials. Arthritis Care & Research. 2024. doi:10.1002/acr.25267
BibTeX
@article{Magrey2024,
author = {Magrey, Marina and Wei, James Cheng-Chung and Yndestad, Arne and Bushmakin, Andrew G and Cappelleri, Joseph C and Dina, Oluwaseyi and Deodhar, Atul},
title = {Relationships of Work Productivity and Activity Impairment With Patient‐Reported Outcomes in Ankylosing Spondylitis: Results From Two Trials},
journal = {Arthritis Care & Research},
year = {2024},
doi = {10.1002/acr.25267}
}
EUVIMED